172 related articles for article (PubMed ID: 9215125)
1. Relation between retinoblastoma and p53 proteins in human papilloma viruses 16/18 positive and negative cancers of the uterine cervix.
Chetty R; Bramdev A; Aguirre-Arteta A; Pegoraro RJ; Sataar N
J Clin Pathol; 1997 May; 50(5):413-6. PubMed ID: 9215125
[TBL] [Abstract][Full Text] [Related]
2. Cervical squamous dysplasias and carcinomas with immunodetectable p53 frequently contain HPV.
Mittal KR; Lin O; Chan W; Goswami S; Demopoulos RI
Gynecol Oncol; 1995 Sep; 58(3):289-94. PubMed ID: 7672694
[TBL] [Abstract][Full Text] [Related]
3. Correlation between human papillomavirus positivity and p53 gene overexpression in adenocarcinoma of the uterine cervix.
Uchiyama M; Iwasaka T; Matsuo N; Hachisuga T; Mori M; Sugimori H
Gynecol Oncol; 1997 Apr; 65(1):23-9. PubMed ID: 9103386
[TBL] [Abstract][Full Text] [Related]
4. Co-overexpression of p53 and bcl-2 proteins in HPV-induced squamous cell carcinoma of the uterine cervix.
Grace VM; Shalini JV; lekha TT; Devaraj SN; Devaraj H
Gynecol Oncol; 2003 Oct; 91(1):51-8. PubMed ID: 14529662
[TBL] [Abstract][Full Text] [Related]
5. Loss of retinoblastoma protein expression is frequent in small cell neuroendocrine carcinoma of the cervix and is unrelated to HPV type.
Herrington CS; Graham D; Southern SA; Bramdev A; Chetty R
Hum Pathol; 1999 Aug; 30(8):906-10. PubMed ID: 10452502
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus DNA in adenocarcinoma and adenosquamous carcinoma of the uterine cervix detected by polymerase chain reaction (PCR).
Yamakawa Y; Forslund O; Teshima H; Hasumi K; Kitagawa T; Hansson BG
Gynecol Oncol; 1994 May; 53(2):190-5. PubMed ID: 8188078
[TBL] [Abstract][Full Text] [Related]
7. Abnormal expression and mutation of p53 in cervical cancer--a study at protein, RNA and DNA levels.
Ngan HY; Tsao SW; Liu SS; Stanley M
Genitourin Med; 1997 Feb; 73(1):54-8. PubMed ID: 9155557
[TBL] [Abstract][Full Text] [Related]
8. A comparative analysis of human papillomavirus types 16 and 18 and expression of p53 gene and Ki-67 in cervical, vaginal, and vulvar carcinomas.
Koyamatsu Y; Yokoyama M; Nakao Y; Fukuda K; Saito T; Matsukuma K; Iwasaka T
Gynecol Oncol; 2003 Sep; 90(3):547-51. PubMed ID: 13678722
[TBL] [Abstract][Full Text] [Related]
9. Presence of human papillomavirus DNA and abnormal p53 protein accumulation in lung carcinoma.
Soini Y; Nuorva K; Kamel D; Pöllänen R; Vähäkangas K; Lehto VP; Pääkkö P
Thorax; 1996 Sep; 51(9):887-93. PubMed ID: 8984698
[TBL] [Abstract][Full Text] [Related]
10. Correlation between p14(ARF)/p16(INK4A) expression and HPV infection in uterine cervical cancer.
Kanao H; Enomoto T; Ueda Y; Fujita M; Nakashima R; Ueno Y; Miyatake T; Yoshizaki T; Buzard GS; Kimura T; Yoshino K; Murata Y
Cancer Lett; 2004 Sep; 213(1):31-7. PubMed ID: 15312681
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical expression of mdm2 and p21WAF1 in invasive cervical cancer: correlation with p53 protein and high risk HPV infection.
Troncone G; Martinez JC; Palombini L; De Rosa G; Mugica C; Rodriguez JA; Zeppa P; Di Vizio D; Lucariello A; Piris MA
J Clin Pathol; 1998 Oct; 51(10):754-60. PubMed ID: 10023338
[TBL] [Abstract][Full Text] [Related]
12. Expression of p16, Rb, and p53 proteins in squamous cell carcinomas of the anorectal region harboring human papillomavirus DNA.
Lu DW; El-Mofty SK; Wang HL
Mod Pathol; 2003 Jul; 16(7):692-9. PubMed ID: 12861066
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus DNA in uterine cervix squamous cell carcinoma and adenocarcinoma detected by polymerase chain reaction.
Iwasawa A; Nieminen P; Lehtinen M; Paavonen J
Cancer; 1996 Jun; 77(11):2275-9. PubMed ID: 8635095
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical expression of 14-3-3 sigma protein in various histological subtypes of uterine cervical cancers.
Sano T; Shimooka H; Weixa P; Segawa A; Jian Z; Motegi A; Nakayama H; Oyama T; Nakajima T
Pathol Int; 2004 Oct; 54(10):743-50. PubMed ID: 15482563
[TBL] [Abstract][Full Text] [Related]
15. High-risk human papillomavirus, tumor suppressor protein p53 and mitomycin-C in invasive squamous cell carcinoma cervix.
Rajaram S; Gupta G; Agarwal S; Goel N; Singh KC
Indian J Cancer; 2006; 43(4):156-62. PubMed ID: 17192686
[TBL] [Abstract][Full Text] [Related]
16. Molecular events in the progression of recurrent respiratory papillomatosis to carcinoma.
Lele SM; Pou AM; Ventura K; Gatalica Z; Payne D
Arch Pathol Lab Med; 2002 Oct; 126(10):1184-8. PubMed ID: 12296755
[TBL] [Abstract][Full Text] [Related]
17. Role of human papillomavirus in the carcinogenesis of squamous cell carcinoma and adenocarcinoma of the cervix.
Tjalma WA; Van Waes TR; Van den Eeden LE; Bogers JJ
Best Pract Res Clin Obstet Gynaecol; 2005 Aug; 19(4):469-83. PubMed ID: 16150388
[TBL] [Abstract][Full Text] [Related]
18. Analysis of human papillomavirus infection and molecular alterations in adenocarcinoma of the cervix.
Ferguson AW; Svoboda-Newman SM; Frank TS
Mod Pathol; 1998 Jan; 11(1):11-8. PubMed ID: 9556417
[TBL] [Abstract][Full Text] [Related]
19. Relation between infection with human papilloma viruses and expression of p21 and p53 oncoproteins in patients with cancer of the uterine cervix.
Bar JK; Markowska J; Harlozińska A; Sedlaczek P; Nowak M; Roszak A
Eur J Gynaecol Oncol; 1996; 17(4):283-5. PubMed ID: 8856306
[TBL] [Abstract][Full Text] [Related]
20. DEK overexpression in uterine cervical cancers.
Wu Q; Li Z; Lin H; Han L; Liu S; Lin Z
Pathol Int; 2008 Jun; 58(6):378-82. PubMed ID: 18477217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
